A T1D Exchange Quality Improvement Collaborative project designed to observe the impact and benefits of initiating continuous glucose monitors (CGMs) within six months of a patient being diagnosed with type 1 diabetes (T1D) was recognized as a President’s Select Abstract of Distinction at the recent American Diabetes Association 83rd Scientific Sessions in San Diego, California, June 23–26. Elizabeth Mann, MD, assistant professor, Division of Endocrinology and Diabetes, offered this work on behalf of the collaborative in the presentation “CGM Initiation within 6 Months of T1D Diagnosis Associated with Lower HbA1c at 3 Years.” The T1D Exchange Quality Improvement Collaborative includes 54 participating clinics from across the country, reaching more than 100,000 people with T1D and type 2 diabetes. Mann is the local PI for the University of Wisconsin’s participation in the collaborative. She also received the Young Investigator Award from the ADA’s Diabetes in Youth Special Interest Group for this work.